wegovy glp-1 agonist Key Lessons for Ethical and Affordable Access to Drugs The obesity drug semaglutide (Wegovy)

Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ

That also could potentially undo any metabolic improvements that can go hand-in-hand with weight loss, such as in diabetes and blood pressure

While enteral administration offers several advantages over other routes of drug delivery in terms of convenience, promoting medication compliance, it faces several obstacles, of which the most widely recognized are inefficient absorption owing to physical barriers and an acidic microenvironment, along with degradation by proteases and the first-pass metabolism in the liver

But PMOS affects much more than cycles and fertility

Aging Cell (2019) 18(3):e12932

Similarly, tirzepatide is more effective at supporting weight loss than semaglutide but seems to have a poorer safety profile